Hepatic Clearance of Drugs in Patients With Renal Insufficiency

被引：11
作者：
Greenblatt, David J. [1 ]
机构：
[1] Tufts Univ, Sch Med, 136 Harrison Ave, Boston, MA 02111 USA
来源：
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT | 2013年 / 2卷 / 04期
关键词：
D O I：
10.1002/cpdd.70
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：295 / 297
页数：3
相关论文
共 25 条
  • [21] ALPRAZOLAM IN END-STAGE RENAL-DISEASE .1. PHARMACOKINETICS
    SCHMITH, VD
    PIRAINO, B
    SMITH, RB
    KROBOTH, PD
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (06) : 571 - 579
  • [22] Effects of renal failure on drug transport and metabolism
    Sun, H
    Frassetto, L
    Benet, LZ
    [J]. PHARMACOLOGY & THERAPEUTICS, 2006, 109 (1-2) : 1 - 11
  • [23] BIOTRANSFORMATION AND EXCRETION OF LORAZEPAM IN PATIENTS WITH CHRONIC RENAL-FAILURE
    VERBEECK, R
    TJANDRAMAGA, TB
    VERBERCKMOES, R
    DESCHEPPER, PJ
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 3 (06) : 1033 - 1039
  • [24] THE PHARMACOKINETICS OF MIDAZOLAM IN CHRONIC-RENAL-FAILURE PATIENTS
    VINIK, HR
    REVES, JG
    GREENBLATT, DJ
    ABERNETHY, DR
    SMITH, LR
    [J]. ANESTHESIOLOGY, 1983, 59 (05) : 390 - 394
  • [25] Assessment of the Impact of Renal Impairment on Systemic Exposure of New Molecular Entities: Evaluation of Recent New Drug Applications
    Zhang, Y.
    Zhang, L.
    Abraham, S.
    Apparaju, S.
    Wu, T-C
    Strong, J. M.
    Xiao, S.
    Atkinson, A. J., Jr.
    Thummel, K. E.
    Leeder, J. S.
    Lee, C.
    Burckart, G. J.
    Lesko, L. J.
    Huang, S-M
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 (03) : 305 - 311
123